Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. https://doi.org/10.3322/caac.21834.

Article  Google Scholar 

Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233–54. https://doi.org/10.3322/caac.21772.

Article  Google Scholar 

Santucci C, Mignozzi S, Malvezzi M, Boffetta P, Collatuzzo G, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2024 with focus on colorectal cancer. Ann Oncol. 2024;35:308–16. https://doi.org/10.1016/j.annonc.2023.12.003.

Article  CAS  Google Scholar 

Moreno-Carmona MR, Serra-Prat M, Riera SA, Estrada O, Ferro T, Querol R. Effect of frailty on postoperative complications, mortality, and survival in older patients with non-metastatic colon cancer: A systematic review and meta-analysis. J Geriatr Oncol. 2024;15:101639. https://doi.org/10.1016/j.jgo.2023.101639.

Article  CAS  Google Scholar 

Cervantes A, Adam R, Roselló S, Arnold D, Normanno N, Taïeb J, Seligmann J, De Baere T, Osterlund P, Yoshino T, Martinelli E. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:10–32. https://doi.org/10.1016/j.annonc.2022.10.003.

Article  CAS  Google Scholar 

Feria A, Times M. Effectiveness of standard treatment for stage 4 colorectal cancer: traditional management with surgery, radiation, and chemotherapy. Clin Colon Rectal Surg. 2024;37:062–5. https://doi.org/10.1055/s-0043-1761420.

Article  Google Scholar 

Tinsley N, O’Dwyer ST, Nagaraju R, Chakrabarty B, Braun M, Mullamitha S, Kamposioras K, Marti Marti FE, Saunders M, Clouston H, Selvasekar C, Wild J, Wilson M, Renehan A, Aziz O, Barriuso J. Preoperative chemotherapy response and survival in patients with colorectal cancer peritoneal metastases. J Surg Oncol. 2024. https://doi.org/10.1002/jso.27776.

Article  Google Scholar 

Kozovska Z, Patsalias A, Bajzik V, Durinikova E, Demkova L, Jargasova S, Smolkova B, Plava J, Kucerova L, Matuskova M. ALDH1A Inhibition sensitizes colon cancer cells to chemotherapy. BMC Cancer. 2018;18:656. https://doi.org/10.1186/s12885-018-4572-6.

Article  CAS  Google Scholar 

Kerr KM, Bubendorf L, Edelman MJ, Marchetti A, Mok T, Novello S, O’Byrne K, Stahel R, Peters S, Felip E, Stahel R, Felip E, Peters S, Kerr K, Besse B, Vansteenkiste J, Eberhardt W, Edelman M, Mok T, O’Byrne K, Novello S, Bubendorf L, Marchetti A, Baas P, Reck M, Syrigos K, Paz-Ares L, Smit EF, Meldgaard P, Adjei A, Nicolson M, Crinò L, Van Schil P, Senan S, Faivre-Finn C, Rocco G, Veronesi G, Douillard J-Y, Lim E, Dooms C, Weder W, De Ruysscher D, Le Pechoux C, De Leyn P, Westeel V. Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Ann Oncol. 2014;25:1681–90. https://doi.org/10.1093/annonc/mdu145.

Article  CAS  Google Scholar 

Guo S, Yao Y, Tang Y, Xin Z, Wu D, Ni C, Huang J, Wei Q, Zhang T. Radiation-induced tumor immune microenvironments and potential targets for combination therapy. Signal Transduct Target Ther. 2023;8:205. https://doi.org/10.1038/s41392-023-01462-z.

Article  Google Scholar 

Parker C, Lewington V, Shore N, Kratochwil C, Levy M, Lindén O, Noordzij W, Park J, Saad F. Targeted alpha therapy, an emerging class of Cancer agents. JAMA Oncol. 2018;4:1765. https://doi.org/10.1001/jamaoncol.2018.4044.

Article  Google Scholar 

Nelson BJB, Andersson JD, Wuest F. Targeted alpha therapy: progress in radionuclide production, radiochemistry, and applications. Pharmaceutics. 2020;13:49. https://doi.org/10.3390/pharmaceutics13010049.

Article  CAS  Google Scholar 

Kim Y-S, Brechbiel MW. An overview of targeted alpha therapy. Tumor Biology. 2012;33:573–90. https://doi.org/10.1007/s13277-011-0286-y.

Article  CAS  Google Scholar 

Serencsits B, Chu BP, Pandit-Taskar N, McDevitt MR, Dauer LT. Radiation safety considerations and clinical advantages of α-Emitting therapy radionuclides. J Nucl Med Technol. 2022;50:10–6. https://doi.org/10.2967/jnmt.121.262294.

Article  Google Scholar 

Griffith DM, Li H, Werrett MV, Andrews PC, Sun H. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles. Chem Soc Rev. 2021;50:12037–69. https://doi.org/10.1039/D0CS00031K.

Article  CAS  Google Scholar 

Poletto G, Evangelista L, Venturini F, Gramegna F, Seno F, Moro S, Vettor R, Realdon N, Cecchin D. Nanoparticles and radioisotopes: A long story in a nutshell. Pharmaceutics. 2022;14:2024. https://doi.org/10.3390/pharmaceutics14102024.

Article  CAS  Google Scholar 

Trencsényi G, Csikos C, Képes Z. Targeted radium alpha therapy in the era of nanomedicine: in vivo results. Int J Mol Sci. 2024;25:664. https://doi.org/10.3390/ijms25010664.

Article  CAS  Google Scholar 

Muslimov AR, Antuganov D, Tarakanchikova YV, Karpov TE, Zhukov MV, Zyuzin MV, Timin AS. An investigation of calcium carbonate core-shell particles for incorporation of 225Ac and sequester of daughter radionuclides: in vitro and in vivo studies. J Controlled Release. 2021;330:726–37. https://doi.org/10.1016/j.jconrel.2021.01.008.

Article  CAS  Google Scholar 

Westrøm S, Malenge M, Jorstad IS, Napoli E, Bruland ØS, Bønsdorff TB, Larsen RH. Ra-224 labeling of calcium carbonate microparticles for internal α‐therapy: preparation, stability, and biodistribution in mice. J Label Comp Radiopharm. 2018;61:472–86. https://doi.org/10.1002/jlcr.3610.

Article  CAS  Google Scholar 

McLaughlin MF, Woodward J, Boll RA, Rondinone AJ, Mirzadeh S, Robertson JD. Gold-coated lanthanide phosphate nanoparticles for an 225 ac in vivo alpha generator. Ract. 2013;101:595–600. https://doi.org/10.1524/ract.2013.2066.

Article  CAS  Google Scholar 

Toro-González M, Dame AN, Mirzadeh S, Rojas JV. Gadolinium vanadate nanocrystals as carriers of α-emitters (225Ac, 227Th) and contrast agents. J Appl Phys. 2019;125. https://doi.org/10.1063/1.5096880.

Cędrowska E, Pruszyński M, Gawęda W, Żuk M, Krysiński P, Bruchertseifer F, Morgenstern A, Karageorgou M-A, Bouziotis P, Bilewicz A. Trastuzumab conjugated superparamagnetic Iron oxide nanoparticles labeled with 225Ac as a perspective tool for combined α-Radioimmunotherapy and magnetic hyperthermia of HER2-Positive breast Cancer. Molecules. 2020;25:1025. https://doi.org/10.3390/molecules25051025.

Article  CAS  Google Scholar 

Cędrowska E, Pruszynski M, Majkowska-Pilip A, Męczyńska-Wielgosz S, Bruchertseifer F, Morgenstern A, Bilewicz A. Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy. J Nanopart Res. 2018;20:83. https://doi.org/10.1007/s11051-018-4181-y.

Article  CAS  Google Scholar 

Matson ML, Villa CH, Ananta JS, Law JJ, Scheinberg DA, Wilson LJ. Encapsulation of α-Particle–Emitting 225 ac 3+ ions within carbon nanotubes. J Nucl Med. 2015;56:897–900. https://doi.org/10.2967/jnumed.115.158311.

Article  CAS  Google Scholar 

Grønningsæter SR, Blakkisrud J, Selboe S, Revheim M-E, Bruland ØS, Bønsdorff TB, Larsen SG, Stokke C. Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis. Front Med (Lausanne). 2023;10. https://doi.org/10.3389/fmed.2023.1058914.

Li RG, Napoli E, Jorstad IS, Bønsdorff TB, Juzeniene A, Bruland ØS, Larsen RH, Westrøm S. Calcium carbonate microparticles as carriers of 224 ra: impact of specific activity in mice with intraperitoneal ovarian Cancer. Curr Radiopharm. 2021;14:145–53. https://doi.org/10.2174/1874471013666201201102056.

Article  CAS  Google Scholar 

Akhmetova DR, Mitusova KA, Postovalova AS, Ivkina AS, Muslimov AR, Zyuzin MV, Shipilovskikh SA, Timin AS. Size-dependent therapeutic efficiency of 223 Ra-labeled calcium carbonate carriers for internal radionuclide therapy of breast cancer. Biomater Sci. 2024;12:453–67. https://doi.org/10.1039/D3BM01651J.

Article  CAS  Google Scholar 

Li RG, Lindland K, Tonstad SK, Bønsdorff TB, Juzeniene A, Westrøm S, Larsen RH. Improved formulation of 224Ra-Labeled calcium carbonate microparticles by surface layer encapsulation and addition of EDTMP. Pharmaceutics. 2021;13:634. https://doi.org/10.3390/pharmaceutics13050634.

Article  CAS  Google Scholar 

Castro-Aguirre E, Iñiguez-Franco F, Samsudin H, Fang X, Auras R. Poly(lactic acid)—Mass production, processing, industrial applications, and end of life. Adv Drug Deliv Rev. 2016;107:333–66. https://doi.org/10.1016/j.addr.2016.03.010.

Article  CAS  Google Scholar 

Freitas MN, Marchetti JM. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases. Int J Pharm. 2005;295:201–11. https://doi.org/10.1016/j.ijpharm.2005.03.003.

Article  CAS  Google Scholar 

Pepe G, Calce E, Verdoliva V, Saviano M, Maglione V, Di Pardo A. De luca, Curcumin-Loaded nanoparticles based on amphiphilic Hyaluronan-Conjugate explored as targeting delivery system for neurodegenerative disorders. Int J Mol Sci. 2020;21:8846. https://doi.org/10.3390/ijms21228846.

Article  CAS  Google Scholar 

Medel S, Syrova Z, Kovacik L, Hrdy J, Hornacek M, Jager E, Hruby M, Lund R, Cmarko D, Stepanek P, Raska I, Nyström B. Curcumin-bortezomib loaded polymeric nanoparticles for synergistic cancer therapy. Eur Polym J. 2017;93:116–31. https://doi.org/10.1016/j.eurpolymj.2017.05.036.

Article  CAS  Google Scholar 

Zhao Y, Huan M, Liu M, Cheng Y, Sun Y, Cui H, Liu D, Mei Q, Zhou S. Doxorubicin and Resveratrol co-delivery nanoparticle to overcome doxorubicin resistance. Sci Rep. 2016;6:35267. https://doi.org/10.1038/srep35267.